NEW YORK (GenomeWeb) – Sigma-Aldrich today said that its pending $17 billion acquisition by Merck KGaA has cleared US antitrust hurdles. 

The waiting period under the Hart-Scott-Rodino Antitrust Improvement Act for the proposed deal expired on Monday, clearing the way for the deal in theUS. Sigma-Aldrich and Merck KGaA are awaiting regulatory approval in other countries but continue to expect the deal to be completed in mid-2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.